Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-16

Clinical Trial Update: Anti-Tumor Necrosis Factor (TNF) Treatments, Work Productivity and Quality of Life in Crohn's Disease

View source ↗

Summary

A completed AbbVie-sponsored clinical trial assessed the impact of Anti-TNF therapies on work productivity and quality of life in Crohn's disease; results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AbbVie | Conditions: Crohn's Disease | Status: COMPLETED | Results posted: 2017-06-16